1. Home
  2. NBTX vs OM Comparison

NBTX vs OM Comparison

Compare NBTX & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • OM
  • Stock Information
  • Founded
  • NBTX 2003
  • OM 2003
  • Country
  • NBTX France
  • OM United States
  • Employees
  • NBTX N/A
  • OM N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NBTX Health Care
  • OM Health Care
  • Exchange
  • NBTX Nasdaq
  • OM Nasdaq
  • Market Cap
  • NBTX 211.9M
  • OM 247.1M
  • IPO Year
  • NBTX 2020
  • OM 2020
  • Fundamental
  • Price
  • NBTX $9.70
  • OM $13.69
  • Analyst Decision
  • NBTX Strong Buy
  • OM Hold
  • Analyst Count
  • NBTX 1
  • OM 1
  • Target Price
  • NBTX $8.00
  • OM $22.00
  • AVG Volume (30 Days)
  • NBTX 15.1K
  • OM 160.2K
  • Earning Date
  • NBTX 09-18-2025
  • OM 11-05-2025
  • Dividend Yield
  • NBTX N/A
  • OM N/A
  • EPS Growth
  • NBTX N/A
  • OM N/A
  • EPS
  • NBTX N/A
  • OM N/A
  • Revenue
  • NBTX N/A
  • OM $119,304,000.00
  • Revenue This Year
  • NBTX N/A
  • OM $12.37
  • Revenue Next Year
  • NBTX $74.67
  • OM $10.52
  • P/E Ratio
  • NBTX N/A
  • OM N/A
  • Revenue Growth
  • NBTX N/A
  • OM 2.47
  • 52 Week Low
  • NBTX $2.76
  • OM $5.85
  • 52 Week High
  • NBTX $10.59
  • OM $25.35
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 62.98
  • OM 45.01
  • Support Level
  • NBTX $8.03
  • OM $13.30
  • Resistance Level
  • NBTX $9.14
  • OM $14.43
  • Average True Range (ATR)
  • NBTX 0.56
  • OM 0.63
  • MACD
  • NBTX -0.02
  • OM 0.16
  • Stochastic Oscillator
  • NBTX 68.67
  • OM 47.89

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Share on Social Networks: